China Cord Blood Corp Cash Flow - Quarterly (NYSE:CO)

Add to My Stocks
$10.52 $0.2 (1.87%) CO stock closing price Feb 16, 2018 (Closing)

The China Cord Blood Corp cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. The profit-loss statement shows China Cord Blood Corp profits, the balance sheet shows China Cord Blood Corp debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. China Cord Blood Corp had cash and cash equivalents of $377.89M at beginning of the quarter and $- at quarter end of 2018 Q2. China Cord Blood Corp cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. China Cord Blood Corp had an outflow of $- from operating activities, $- spend due to financing activities, and $- outflow due to investing activities till 2018 Q2.

View and download details of China Cord Blood Corp cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Apr - Mar2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow--7.9M---8.35M--
Net Increase (Decrease) in Assets Liabilities--46.78M---46.39M--
Cash From (used in) Discontinued Operations---------
Other Adjustments Net--19.25M---21.19M--
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment---3.54M--2.71M--2.55M--
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments---9.61M--9.92M----
Other Cash Inflow (Outflow) from Investment Activities---------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares---------
Issuance (Repayment) of Debt Securities---------
Increase (Decrease) in Bank & Other Borrowings---8.71M--8.99M----
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities-------0.25M--
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash--2.14M-1.68M-1.38M--
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year377.89M303.74M240.34M127.89M97.08M42.88M23.64M--
Cash & Equivalents at Year End--509.97M-471.26M-466.56M--
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While China Cord Blood Corp stock price history provides the price history of a stock, China Cord Blood Corp stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that China Cord Blood Corp is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - China Cord Blood Corp stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $- for CO.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $- for CO stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. China Cord Blood Corp spent $- from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For China Cord Blood Corp Cash Flow

FCF margin

Quarterly Cash Flow Statements For China Cord Blood Corp Peers

Amedisys cash flow, LHC cash flow, Pharmerica cash flow, Surgical Care Affiliates cash flow